{"entity":{"type":"insider","cik":"0001785557","url":"/insider/0001785557","json_url":"/insider/0001785557.json","name":"JOHNSON DAVID EDWARD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":20,"first":"2022-04-08","last":"2026-05-20","span_basis":"filed_date"},"name_variants":[{"name":"JOHNSON DAVID EDWARD","source":"filing","n_filings":20,"first_seen":"2022-04-08","last_seen":"2026-05-20"}],"transactions":[{"id":6080671,"accession":"0000902664-26-002578","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-26-002578","line_url":"/filing/0000902664-26-002578#line-2","is_derivative":false,"issuer_cik":"0001727492","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001727492","owner_cik":null,"owner_name":"Caligan Partners LP; JOHNSON DAVID EDWARD","owner_display_name":"Caligan Partners LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (\"Common Stock\")","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":59.98,"price_display":"59.98","price_state":"stated","total_value":317894.0,"total_display":"317,894.00","total_whole":"317,894","shares_owned_after":8133651.0,"shares_owned_after_display":"8,133,651","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-19","filed_date":"2026-05-20","scope":"insider"},{"id":6080667,"accession":"0000902664-26-002578","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-26-002578","line_url":"/filing/0000902664-26-002578#line-1","is_derivative":false,"issuer_cik":"0001727492","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001727492","owner_cik":null,"owner_name":"Caligan Partners LP; JOHNSON DAVID EDWARD","owner_display_name":"Caligan Partners LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5300.0,"shares_display":"5,300","price_per_share":59.98,"price_display":"59.98","price_state":"stated","total_value":317894.0,"total_display":"317,894.00","total_whole":"317,894","shares_owned_after":8138951.0,"shares_owned_after_display":"8,138,951","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-19","filed_date":"2026-05-20","scope":"insider"},{"id":5189796,"accession":"0000902664-25-005164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-25-005164","line_url":"/filing/0000902664-25-005164#line-1","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27532.0,"shares_display":"27,532","price_per_share":43.122,"price_display":"43.12","price_state":"stated","total_value":1187234.904,"total_display":"1,187,234.90","total_whole":"1,187,235","shares_owned_after":1553262.0,"shares_owned_after_display":"1,553,262","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":2456273,"accession":"0000902664-24-005425","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-24-005425","line_url":"/filing/0000902664-24-005425#line-2","is_derivative":false,"issuer_cik":"0001727492","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001727492","owner_cik":null,"owner_name":"Caligan Partners LP; JOHNSON DAVID EDWARD","owner_display_name":"Caligan Partners LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":9.51,"price_display":"9.51","price_state":"stated","total_value":1426500.0,"total_display":"1,426,500.00","total_whole":"1,426,500","shares_owned_after":6844997.0,"shares_owned_after_display":"6,844,997","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-30","filed_date":"2024-09-04","scope":"insider"},{"id":2456268,"accession":"0000902664-24-005425","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-24-005425","line_url":"/filing/0000902664-24-005425#line-1","is_derivative":false,"issuer_cik":"0001727492","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001727492","owner_cik":null,"owner_name":"Caligan Partners LP; JOHNSON DAVID EDWARD","owner_display_name":"Caligan Partners LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":9.51,"price_display":"9.51","price_state":"stated","total_value":1426500.0,"total_display":"1,426,500.00","total_whole":"1,426,500","shares_owned_after":6994997.0,"shares_owned_after_display":"6,994,997","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-30","filed_date":"2024-09-04","scope":"insider"},{"id":3016020,"accession":"0000902664-24-003949","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-24-003949","line_url":"/filing/0000902664-24-003949#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":null,"owner_name":"Caligan Partners LP; JOHNSON DAVID EDWARD","owner_display_name":"Caligan Partners LP","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":225000.0,"shares_display":"225,000","price_per_share":20.7558,"price_display":"20.76","price_state":"stated","total_value":4670055.0,"total_display":"4,670,055.00","total_whole":"4,670,055","shares_owned_after":1525730.0,"shares_owned_after_display":"1,525,730","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-30","filed_date":"2024-05-30","scope":"insider"},{"id":3016013,"accession":"0000902664-24-003949","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-24-003949","line_url":"/filing/0000902664-24-003949#line-1","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":null,"owner_name":"Caligan Partners LP; JOHNSON DAVID EDWARD","owner_display_name":"Caligan Partners LP","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":20.3195,"price_display":"20.32","price_state":"stated","total_value":4063900.0,"total_display":"4,063,900.00","total_whole":"4,063,900","shares_owned_after":1300730.0,"shares_owned_after_display":"1,300,730","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-30","scope":"insider"},{"id":2975887,"accession":"0000902664-24-001966","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-24-001966","line_url":"/filing/0000902664-24-001966#line-1","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":null,"owner_name":"Caligan Partners LP; JOHNSON DAVID EDWARD","owner_display_name":"Caligan Partners LP","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":190000.0,"shares_display":"190,000","price_per_share":20.6986,"price_display":"20.70","price_state":"stated","total_value":3932734.0,"total_display":"3,932,734.00","total_whole":"3,932,734","shares_owned_after":1100730.0,"shares_owned_after_display":"1,100,730","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-21","filed_date":"2024-02-22","scope":"insider"},{"id":8570055,"accession":"0000902664-23-005873","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-23-005873","line_url":"/filing/0000902664-23-005873#line-1","is_derivative":false,"issuer_cik":"0001727492","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001727492","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1117318.0,"shares_display":"1,117,318","price_per_share":7.16,"price_display":"7.16","price_state":"stated","total_value":7999996.88,"total_display":"7,999,996.88","total_whole":"7,999,997","shares_owned_after":11280945.0,"shares_owned_after_display":"11,280,945","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-14","scope":"insider"},{"id":7887229,"accession":"0000902664-23-005732","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-23-005732","line_url":"/filing/0000902664-23-005732#line-2","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120409.0,"shares_display":"120,409","price_per_share":21.61,"price_display":"21.61","price_state":"stated","total_value":2602038.49,"total_display":"2,602,038.49","total_whole":"2,602,038","shares_owned_after":790321.0,"shares_owned_after_display":"790,321","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-27","filed_date":"2023-11-29","scope":"insider"},{"id":7887225,"accession":"0000902664-23-005732","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-23-005732","line_url":"/filing/0000902664-23-005732#line-1","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120409.0,"shares_display":"120,409","price_per_share":21.61,"price_display":"21.61","price_state":"stated","total_value":2602038.49,"total_display":"2,602,038.49","total_whole":"2,602,038","shares_owned_after":910730.0,"shares_owned_after_display":"910,730","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-27","filed_date":"2023-11-29","scope":"insider"},{"id":7939505,"accession":"0000902664-23-004790","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-23-004790","line_url":"/filing/0000902664-23-004790#line-2","is_derivative":false,"issuer_cik":"0001267602","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001267602","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value 0.01 per share (Common Stock)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":579000.0,"shares_display":"579,000","price_per_share":3.39,"price_display":"3.39","price_state":"stated","total_value":1962810.0,"total_display":"1,962,810.00","total_whole":"1,962,810","shares_owned_after":16256154.0,"shares_owned_after_display":"16,256,154","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-14","filed_date":"2023-09-15","scope":"insider"},{"id":7939501,"accession":"0000902664-23-004790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-23-004790","line_url":"/filing/0000902664-23-004790#line-1","is_derivative":false,"issuer_cik":"0001267602","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001267602","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":579000.0,"shares_display":"579,000","price_per_share":3.39,"price_display":"3.39","price_state":"stated","total_value":1962810.0,"total_display":"1,962,810.00","total_whole":"1,962,810","shares_owned_after":16835154.0,"shares_owned_after_display":"16,835,154","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-14","filed_date":"2023-09-15","scope":"insider"},{"id":6981905,"accession":"0000902664-22-004182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-22-004182","line_url":"/filing/0000902664-22-004182#line-1","is_derivative":false,"issuer_cik":"0001727492","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001727492","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":5.62,"price_display":"5.62","price_state":"stated","total_value":1405000.0,"total_display":"1,405,000.00","total_whole":"1,405,000","shares_owned_after":10643627.0,"shares_owned_after_display":"10,643,627","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-06","filed_date":"2022-09-07","scope":"insider"},{"id":6118375,"accession":"0000902664-22-003823","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-22-003823","line_url":"/filing/0000902664-22-003823#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":255173.0,"shares_display":"255,173","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":446552.75,"total_display":"446,552.75","total_whole":"446,553","shares_owned_after":11444836.0,"shares_owned_after_display":"11,444,836","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-04","filed_date":"2022-08-05","scope":"insider"},{"id":6118370,"accession":"0000902664-22-003823","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-22-003823","line_url":"/filing/0000902664-22-003823#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":46009.0,"shares_display":"46,009","price_per_share":1.74,"price_display":"1.74","price_state":"stated","total_value":80055.66,"total_display":"80,055.66","total_whole":"80,056","shares_owned_after":11189663.0,"shares_owned_after_display":"11,189,663","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-03","filed_date":"2022-08-05","scope":"insider"},{"id":6319490,"accession":"0000902664-22-003778","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-22-003778","line_url":"/filing/0000902664-22-003778#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":272618.0,"shares_display":"272,618","price_per_share":1.64,"price_display":"1.64","price_state":"stated","total_value":447093.52,"total_display":"447,093.52","total_whole":"447,094","shares_owned_after":11143654.0,"shares_owned_after_display":"11,143,654","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-02","scope":"insider"},{"id":6319487,"accession":"0000902664-22-003778","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-22-003778","line_url":"/filing/0000902664-22-003778#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":210200.0,"shares_display":"210,200","price_per_share":1.48,"price_display":"1.48","price_state":"stated","total_value":311096.0,"total_display":"311,096.00","total_whole":"311,096","shares_owned_after":10871036.0,"shares_owned_after_display":"10,871,036","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-02","scope":"insider"},{"id":6319483,"accession":"0000902664-22-003778","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-22-003778","line_url":"/filing/0000902664-22-003778#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (Common Stock)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":137648.0,"shares_display":"137,648","price_per_share":1.42,"price_display":"1.42","price_state":"stated","total_value":195460.16,"total_display":"195,460.16","total_whole":"195,460","shares_owned_after":10660836.0,"shares_owned_after_display":"10,660,836","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-29","filed_date":"2022-08-02","scope":"insider"},{"id":6451551,"accession":"0000902664-22-003296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-22-003296","line_url":"/filing/0000902664-22-003296#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":170000.0,"total_display":"170,000.00","total_whole":"170,000","shares_owned_after":10523188.0,"shares_owned_after_display":"10,523,188","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-13","filed_date":"2022-06-15","scope":"insider"},{"id":6674223,"accession":"0000902664-22-003177","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-22-003177","line_url":"/filing/0000902664-22-003177#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":1.98,"price_display":"1.98","price_state":"stated","total_value":495000.0,"total_display":"495,000.00","total_whole":"495,000","shares_owned_after":10423188.0,"shares_owned_after_display":"10,423,188","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-06","scope":"insider"},{"id":6674217,"accession":"0000902664-22-003177","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-22-003177","line_url":"/filing/0000902664-22-003177#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.92,"price_display":"1.92","price_state":"stated","total_value":384000.0,"total_display":"384,000.00","total_whole":"384,000","shares_owned_after":10173188.0,"shares_owned_after_display":"10,173,188","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-06","scope":"insider"},{"id":6589425,"accession":"0000902664-22-003105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-22-003105","line_url":"/filing/0000902664-22-003105#line-1","is_derivative":false,"issuer_cik":"0001727492","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001727492","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":79400.0,"shares_display":"79,400","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":269960.0,"total_display":"269,960.00","total_whole":"269,960","shares_owned_after":10393627.0,"shares_owned_after_display":"10,393,627","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-26","scope":"insider"},{"id":6805203,"accession":"0000902664-22-003037","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-22-003037","line_url":"/filing/0000902664-22-003037#line-3","is_derivative":false,"issuer_cik":"0001727492","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001727492","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":85000.0,"shares_display":"85,000","price_per_share":5.81,"price_display":"5.81","price_state":"stated","total_value":493850.0,"total_display":"493,850.00","total_whole":"493,850","shares_owned_after":10314227.0,"shares_owned_after_display":"10,314,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-19","scope":"insider"},{"id":6805197,"accession":"0000902664-22-003037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-22-003037","line_url":"/filing/0000902664-22-003037#line-2","is_derivative":false,"issuer_cik":"0001727492","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001727492","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":76404.0,"shares_display":"76,404","price_per_share":5.89,"price_display":"5.89","price_state":"stated","total_value":450019.56,"total_display":"450,019.56","total_whole":"450,020","shares_owned_after":10229227.0,"shares_owned_after_display":"10,229,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-19","scope":"insider"},{"id":6805186,"accession":"0000902664-22-003037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-22-003037","line_url":"/filing/0000902664-22-003037#line-1","is_derivative":false,"issuer_cik":"0001727492","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001727492","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":59700.0,"shares_display":"59,700","price_per_share":5.99,"price_display":"5.99","price_state":"stated","total_value":357603.0,"total_display":"357,603.00","total_whole":"357,603","shares_owned_after":10152823.0,"shares_owned_after_display":"10,152,823","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider"},{"id":6319480,"accession":"0000902664-22-002849","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-22-002849","line_url":"/filing/0000902664-22-002849#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.52,"price_display":"2.52","price_state":"stated","total_value":63000.0,"total_display":"63,000.00","total_whole":"63,000","shares_owned_after":9973188.0,"shares_owned_after_display":"9,973,188","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-10","scope":"insider"},{"id":6319477,"accession":"0000902664-22-002849","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-22-002849","line_url":"/filing/0000902664-22-002849#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (Common Stock)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":463350.0,"shares_display":"463,350","price_per_share":2.9,"price_display":"2.90","price_state":"stated","total_value":1343715.0,"total_display":"1,343,715.00","total_whole":"1,343,715","shares_owned_after":9948188.0,"shares_owned_after_display":"9,948,188","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-06","filed_date":"2022-05-10","scope":"insider"},{"id":6291714,"accession":"0000902664-22-002740","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-22-002740","line_url":"/filing/0000902664-22-002740#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Caligan Partners LP; JOHNSON DAVID EDWARD","owner_display_name":"Caligan Partners LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":2.81,"price_display":"2.81","price_state":"stated","total_value":351250.0,"total_display":"351,250.00","total_whole":"351,250","shares_owned_after":9484838.0,"shares_owned_after_display":"9,484,838","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-02","scope":"insider"},{"id":6291712,"accession":"0000902664-22-002740","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-22-002740","line_url":"/filing/0000902664-22-002740#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Caligan Partners LP; JOHNSON DAVID EDWARD","owner_display_name":"Caligan Partners LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":247400.0,"shares_display":"247,400","price_per_share":2.66,"price_display":"2.66","price_state":"stated","total_value":658084.0,"total_display":"658,084.00","total_whole":"658,084","shares_owned_after":9359838.0,"shares_owned_after_display":"9,359,838","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-29","filed_date":"2022-05-02","scope":"insider"},{"id":6291710,"accession":"0000902664-22-002740","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-22-002740","line_url":"/filing/0000902664-22-002740#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Caligan Partners LP; JOHNSON DAVID EDWARD","owner_display_name":"Caligan Partners LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27600.0,"shares_display":"27,600","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":66240.0,"total_display":"66,240.00","total_whole":"66,240","shares_owned_after":9112438.0,"shares_owned_after_display":"9,112,438","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-05-02","scope":"insider"},{"id":6945596,"accession":"0000902664-22-002594","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-22-002594","line_url":"/filing/0000902664-22-002594#line-1","is_derivative":false,"issuer_cik":"0001727492","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001727492","owner_cik":null,"owner_name":"Caligan Partners LP; JOHNSON DAVID EDWARD","owner_display_name":"Caligan Partners LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1764705.0,"shares_display":"1,764,705","price_per_share":5.1,"price_display":"5.10","price_state":"stated","total_value":8999995.5,"total_display":"8,999,995.50","total_whole":"8,999,996","shares_owned_after":10093123.0,"shares_owned_after_display":"10,093,123","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-18","filed_date":"2022-04-18","scope":"insider"},{"id":6621025,"accession":"0000902664-22-002542","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-22-002542","line_url":"/filing/0000902664-22-002542#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":180000.0,"total_display":"180,000.00","total_whole":"180,000","shares_owned_after":9084838.0,"shares_owned_after_display":"9,084,838","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-12","filed_date":"2022-04-13","scope":"insider"},{"id":6621020,"accession":"0000902664-22-002542","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-22-002542","line_url":"/filing/0000902664-22-002542#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"JOHNSON DAVID EDWARD; Caligan Partners LP","owner_display_name":"JOHNSON DAVID EDWARD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":145000.0,"shares_display":"145,000","price_per_share":3.87,"price_display":"3.87","price_state":"stated","total_value":561150.0,"total_display":"561,150.00","total_whole":"561,150","shares_owned_after":9034838.0,"shares_owned_after_display":"9,034,838","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-13","scope":"insider"},{"id":6472665,"accession":"0000902664-22-002486","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-22-002486","line_url":"/filing/0000902664-22-002486#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Caligan Partners LP; JOHNSON DAVID EDWARD","owner_display_name":"Caligan Partners LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":3.76,"price_display":"3.76","price_state":"stated","total_value":752000.0,"total_display":"752,000.00","total_whole":"752,000","shares_owned_after":8889838.0,"shares_owned_after_display":"8,889,838","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-08","filed_date":"2022-04-08","scope":"insider"},{"id":6472662,"accession":"0000902664-22-002486","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-22-002486","line_url":"/filing/0000902664-22-002486#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Caligan Partners LP; JOHNSON DAVID EDWARD","owner_display_name":"Caligan Partners LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":3.88,"price_display":"3.88","price_state":"stated","total_value":776000.0,"total_display":"776,000.00","total_whole":"776,000","shares_owned_after":8689838.0,"shares_owned_after_display":"8,689,838","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-07","filed_date":"2022-04-08","scope":"insider"},{"id":6472659,"accession":"0000902664-22-002486","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-22-002486","line_url":"/filing/0000902664-22-002486#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Caligan Partners LP; JOHNSON DAVID EDWARD","owner_display_name":"Caligan Partners LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":109573.0,"shares_display":"109,573","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":394462.8,"total_display":"394,462.80","total_whole":"394,463","shares_owned_after":8489838.0,"shares_owned_after_display":"8,489,838","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-06","filed_date":"2022-04-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819576","name":"Liquidia Corp","url":"/issuer/0001819576","role":"Director, Ten percent owner, Other","n_filings":7,"first_seen":"2022-04-18","last_seen":"2026-05-20"},{"type":"issuer","type_label":"ISSUER","cik":"0000939767","name":"EXELIXIS, INC.","url":"/issuer/0000939767","role":"Director","n_filings":4,"first_seen":"2023-11-29","last_seen":"2025-11-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001267602","name":"ALIMERA SCIENCES INC","url":"/issuer/0001267602","role":"Ten percent owner","n_filings":1,"first_seen":"2023-09-15","last_seen":"2023-09-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001162194","name":"STANDARD BIOTOOLS INC.","url":"/issuer/0001162194","role":"Ten percent owner","n_filings":8,"first_seen":"2022-04-08","last_seen":"2022-08-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001785557","retrieved_at":"2026-08-25T12:44:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}